Australia's Mayne Pharma rises as annual loss narrows

Mayne Pharma

29/08/2025 02:14

** Shares of Mayne Pharma MYX.AX rise as much as 10.7% to A$5.570, their highest level since May 16

** Stock logs its biggest intraday pct gain since June 5

** The dermatology and women's health company posts annual net loss of A$90.1 million ($58.55 million), compared with a loss of A$168.6 million logged a year earlier

** Co also reports annual revenue of A$408.1 million, a 5% increase from last year

** Stock up nearly 7% this year, including the day's move

($1 = 1.5389 Australian dollars)

 (Reporting by Rajasik Mukherjee in Bengaluru)

 ((Rajasik.Mukherjee@thomsonreuters.com))